✨ Free AI Report
CNBX Pharmaceuticals Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview CNBX Pharmaceuticals Inc.
Research Preview

CNBX Pharmaceuticals Inc.: Business Overview, Financials & Competitive Analysis

CNBX Pharmaceuticals Inc. is a clinical stage company dedicated to discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment of cancer. The company ...

Analyst-debate audio for CNBX Pharmaceuticals Inc.

AskCyborg analysts argue the bull and bear cases for CNBX Pharmaceuticals Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
CNBX Pharmaceuticals Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
1/ 10Critical

Cyborg Score thesis

Undercapitalized clinical-stage cannabinoid oncology company with minimal cash runway and no approved products, representing...

Read the full analyst-debate transcript →
Industry Oncology Drugs
2 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 5, 2026
AI-Verified Research
30+ Page Report

Get the Latest CNBX Pharmaceuticals Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

CNBX Pharmaceuticals Inc. Overview

Pro stress-test →

CNBX Pharmaceuticals Inc. is a clinical stage company dedicated to discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment of cancer. The company specializes in research and development of proprietary formulations aimed at treating various types of cancer, including colorectal cancer, melanoma, breast cancer, and prostate cancer, utilizing high throughput screening technology and advanced bioinformatics.

Strategic Profile

Pro stress-test →

The company's lead product candidate is Cannabics SR, an oral capsule for advanced cancer and cancer anorexia cachexia syndrome (CACS), with RCC-33 as the leading anti-neoplastic drug candidate under development for colorectal cancer. R&D is conducted in a government-licensed lab facility in Israel with focus on development of cannabinoid-based therapies, medications and administration routes for cancer treatment.

Competitive Landscape

Pro stress-test →

CNBX competes in the niche cannabinoid-based oncology segment against specialized pharmaceutical and biotechnology firms developing cannabinoid therapeutics for cancer. Competition includes companies pursuing cannabis-derived drug candidates, though CNBX's specific focus on formulated cannabinoids for gastrointestinal and dermatological cancers remains relatively specialized. The broader oncology therapeutics market includes major pharmaceutical companies and numerous biotech firms.

Industry Context

CNBX Pharmaceuticals Inc. operates in Oncology Drugs.

Key facts

Founded: 2004 · Headquarters: Bethesda, Maryland, United States · Employees: 1 · Revenue: Estimated $0.13M-$0.41M annually (based on FY2024 laboratory services revenue of $130,074)

What the analysts stress-tested

The top findings that survived the multi-agent debate for CNBX Pharmaceuticals Inc..

+1 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when CNBX Pharmaceuticals Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Zynerba PharmaceuticalsCannabinoid-based pharmaceutical development for neurological and psychiatric conditions→ZogenixDevelopment of cannabinoid-based therapeutics for rare seizure disorders and related conditions→

Compare CNBX Pharmaceuticals Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

CNBX Pharmaceuticals Inc. operates in Oncology Drugs. See how the rest of the sector scores on the Cyborg framework.

Browse Oncology Drugs research →
NEW · MCP server

Ask your AI assistant about CNBX Pharmaceuticals Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare CNBX Pharmaceuticals Inc. and its top competitor on Cyborg Score”
“What did CNBX Pharmaceuticals Inc. do this quarter?”
“Is CNBX Pharmaceuticals Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does CNBX Pharmaceuticals Inc. do?+
CNBX Pharmaceuticals Inc. is a clinical stage company dedicated to discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment of cancer. The company ...
What is CNBX Pharmaceuticals Inc.'s Cyborg Score?+
CNBX Pharmaceuticals Inc. has a Cyborg Score of 1/10 (Critical). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are CNBX Pharmaceuticals Inc.'s main competitors?+
Named competitors include Zynerba Pharmaceuticals, Zogenix. The full competitive landscape is in the AskCyborg report.
How can I get the full CNBX Pharmaceuticals Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the CNBX Pharmaceuticals Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track CNBX Pharmaceuticals Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.